Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Melasma in Skin of Colour: 2024 Update

Description

The update on melasma treatment in skin of color emphasizes the importance of recognizing extra facial sites of melasma and understanding its complex etiologies, including endocrine factors and vascular issues. When considering chemical peels for treatment, superficial peels are preferred due to their lower risk of complications compared to deeper peels, particularly in darker skin types. The presentation discusses the optimal selection of chemical peels, the benefits of priming the skin with topical agents prior to treatment, and highlights the efficacy of glycolic and salicylic acids, particularly when combined with microdermabrasion. Additionally, newer techniques like segmental and sequential peeling are recommended for more resistant cases. It is crucial to manage patient expectations, with a high recurrence rate of melasma (90-95%) and possible patient dissatisfaction after treatment. The role of lasers is acknowledged, noting that while effective, lasers should be considered adjunctively rather than as first-line treatments to avoid complications. The summary reinforces the need for cautious application of treatments, thorough patient counseling, and collaboration among healthcare providers to optimize outcomes and minimize treatment mismatches for patients with darker skin.

View more

Conclusions

  • Melasma can occur on non-facial areas such as the neck and upper back, indicating a need for broader assessment in patients.
  • Understanding the etiology of melasma is crucial for effective treatment, including new factors such as endocrine influences and vascular components.
  • Chemical peels are an adjunctive therapy, with superficial peels preferred for melasma in skin of color due to lower risks of complications.
  • Patients with early melasma and heterogeneous pigmentation patterns are more likely to respond favorably to chemical peels.
  • Priming the skin before chemical peels enhances treatment outcomes and reduces side effects.
  • Microdermabrasion combined with chemical peels may provide superior results for melasma treatment, especially in darker skin types.
  • Laser treatments can be beneficial for melasma but should not be the first line of treatment and must be used cautiously in skin of color due to risks of post-inflammatory hyperpigmentation.
  • Patient counseling is essential to manage expectations, as melasma often recurs after treatment, leading to dissatisfaction.
  • Utilizing individual treatment plans that incorporate both peels and lasers can improve efficacy and safety in managing melasma.
  • Sanchez et al., Classification of Melasma and its Prognostic Implications. Dermatology.
  • Sarkar R, Arsiwala S, Dubey N, et al. Chemical Peels in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017 Nov-Dec;62(6):578-584.
  • AShah SD, Aurangabadkar SJ. Laser Toning in Melasma. J Cutan Aesthet Surg. 2019 Apr-Jun;12(2):76-84.
  • Sarkar R, Aurangabadkar S, Salim T, et al. Lasers in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017 Nov-Dec;62(6):585-590.
  • Lai D, Zhou S, Cheng S, Liu H, Cui Y. Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci. 2022 Jun;37(4):2099-2110.